ReviewComputational and structural biotechnology journal2022
Proteotranscriptomics - A facilitator in omics research.
Review in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Insights from Mass Spectrometry-Based Proteomics onJournal of fungi (Basel, Switzerland) · 2025Review
- Characterization and comparative analysis of sericin protein 150 in Bombyx mori.Scientific reports · 2024Article
- Article
- A Proteomic Analysis for the Red SeaweedBiology · 2023Article
- Nematode gene annotation by machine-learning-assisted proteotranscriptomics enables proteome-wide evolutionary analysis.Genome research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Applications in omics research, such as comparative transcriptomics and proteomics, require the knowledge of the species-specific gene sequence and benefit from a comprehensive high-quality annotation of the coding genes to achieve high coverage. While protein-coding genes can in simple cases be detected by scanning the genome for open reading frames, in more complex genomes exonic sequences are separated by introns. Despite advances in sequencing technologies that allow for ever-growing numbers of genomes, the quality of many of the provided genome assemblies do not reach reference quality. These non-contiguous assemblies with gaps and the necessity to predict splice sites limit accurate gene annotation from solely genomic data. In contrast, the transcriptome only contains transcribed gene regions, is devoid of introns and thus provides the optimal basis for the identification of open reading frames. The additional integration of proteomics data to validate predicted protein-coding genes further enriches for accurate gene models. This review outlines the principles of the proteotranscriptomics approach, discusses common challenges and suggests methods for improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.